Physician profile
John H Suh
NPI 1528025764
$16,284.34
in general payments reported to CMS, 2019-2025
13 companies · $634 in 2025
The $634 reported for 2025 was more than what 78% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $2,575 · 2021: $5,380 · 2022: $6,767 · 2023: $297 · 2024: $444 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $13,743.58 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $614.81 | 2022-2025 | Clinac Ix |
| Elekta, INC. | $597.99 | 2021-2025 | Elekta Unity |
| Icotec Medical INC. | $251.26 | 2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm |
| Medtronic, INC. | $247.42 | 2022 | |
| Varian Medical Systems, INC. | $195.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $164.05 | 2021-2024 | Dificid |
| Daiichi Sankyo INC. | $153.00 | 2021-2025 | Injectafer |
| Ge Healthcare | $114.22 | 2023 | |
| Iba Proton Therapy, INC. | $92.00 | 2023 | |
| Abbvie INC. | $51.75 | 2019 | |
| Novocure Gmbh | $44.46 | 2025 | Optune Gio |
| Ironwood Pharmaceuticals, INC | $14.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Suh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.